中国基层医药
中國基層醫藥
중국기층의약
CHINESE JOURNAL OF PRIMARY MEDICINE AND PHARMACY
2014年
22期
3420-3422
,共3页
吕绪广%王亮%司蓓%马颖颖
呂緒廣%王亮%司蓓%馬穎穎
려서엄%왕량%사배%마영영
肺肿瘤%肺切除术
肺腫瘤%肺切除術
폐종류%폐절제술
Lung neoplasms%Pneumonectomy
目的:观察对比分析袖状切除术与楔形切除术在支气管肺癌治疗中的效果。方法选取100例支气管肺癌患者作为研究对象,选用随机表格法,将所有患者分为观察组(50例,给予袖状切除术治疗),对照组(50例,给予楔形切除术治疗),分别在术后进行相应的辅助治疗,治疗结束后随访3年。结果术后近期疗效比较中,观察组吻合口瘘发生率与病死率分别为4%、6%,对照组为6%、8%,两组差异均无统计学意义(χ2=0.00、0.00,均P>0.05);观察组支气管残端癌细胞阳性率为4%,明显低于对照组的16%(χ2=4.00,P<0.05)。观察组在随访期内的吻合口瘢痕组织增生率与复发率分别为2%、2%,均低于对照组的16%、18%(χ2=4.40、7.11,均P<0.05)。观察组1、3年生存率分别为92%、64%,均显著高于对照组的62%、42%(χ2=12.70、4.86,均P<0.05)。结论采取袖状切除术治疗支气管肺癌,能够有效控制患者的支气管残端癌细胞阳性率,抑制吻合口瘢痕组织增生,减少复发率,并且远期疗效非常理想,值得在临床中推广应用。
目的:觀察對比分析袖狀切除術與楔形切除術在支氣管肺癌治療中的效果。方法選取100例支氣管肺癌患者作為研究對象,選用隨機錶格法,將所有患者分為觀察組(50例,給予袖狀切除術治療),對照組(50例,給予楔形切除術治療),分彆在術後進行相應的輔助治療,治療結束後隨訪3年。結果術後近期療效比較中,觀察組吻閤口瘺髮生率與病死率分彆為4%、6%,對照組為6%、8%,兩組差異均無統計學意義(χ2=0.00、0.00,均P>0.05);觀察組支氣管殘耑癌細胞暘性率為4%,明顯低于對照組的16%(χ2=4.00,P<0.05)。觀察組在隨訪期內的吻閤口瘢痕組織增生率與複髮率分彆為2%、2%,均低于對照組的16%、18%(χ2=4.40、7.11,均P<0.05)。觀察組1、3年生存率分彆為92%、64%,均顯著高于對照組的62%、42%(χ2=12.70、4.86,均P<0.05)。結論採取袖狀切除術治療支氣管肺癌,能夠有效控製患者的支氣管殘耑癌細胞暘性率,抑製吻閤口瘢痕組織增生,減少複髮率,併且遠期療效非常理想,值得在臨床中推廣應用。
목적:관찰대비분석수상절제술여설형절제술재지기관폐암치료중적효과。방법선취100례지기관폐암환자작위연구대상,선용수궤표격법,장소유환자분위관찰조(50례,급여수상절제술치료),대조조(50례,급여설형절제술치료),분별재술후진행상응적보조치료,치료결속후수방3년。결과술후근기료효비교중,관찰조문합구루발생솔여병사솔분별위4%、6%,대조조위6%、8%,량조차이균무통계학의의(χ2=0.00、0.00,균P>0.05);관찰조지기관잔단암세포양성솔위4%,명현저우대조조적16%(χ2=4.00,P<0.05)。관찰조재수방기내적문합구반흔조직증생솔여복발솔분별위2%、2%,균저우대조조적16%、18%(χ2=4.40、7.11,균P<0.05)。관찰조1、3년생존솔분별위92%、64%,균현저고우대조조적62%、42%(χ2=12.70、4.86,균P<0.05)。결론채취수상절제술치료지기관폐암,능구유효공제환자적지기관잔단암세포양성솔,억제문합구반흔조직증생,감소복발솔,병차원기료효비상이상,치득재림상중추엄응용。
Objective To make contrast analysis of sleeve lobectomy and wedge resection in lung cancer treatment by observing the clinical curative effect.Methods 100 patients with lung cancer using random table method, all the patients were divided into the observation group ( 50 cases, treated with sleeve resection ) , control group (50 cases,treated with wedge resection),follow-up after treatment lasted respectively for 3 years.Results In the two groups,anastomotic fistula incidence and mortality rates of the observation group were 4%,6%;6% and 8% in the control group,there were no statistical difference (χ2 =0.00,0.00,all P>0.05);the positive rate of stump cancer cell bronchial in the observation group was 4%,it was obviously less than 16% in the control group,and the differ-ence was obvious (χ2 =4.00,P<0.05) .The anastomotic scar tissue hyperplasia and recurrence rate of the observa-tion group during the follow-up period were 2%,2%;which were lower than 16%,18% of the control group (χ2 =4.40,7.11,all P<0.05).The 1,3 year survival rates of the observation group were 92%,64%,which were higher than 62%and 42%of the control group (χ2 =12.70,4.86,all P<0.05).Conclusion Taking sleeve resection for bronchogenic carcinoma can effectively control the positive rate of bronchial stump with cancer cells,inhibit anasto-motic scar tissue hyperplasia,reduce the recurrence rate,and the curative effect is very good,which is worth of clinical application.